Velcade for Proliferative Lupus Nephritis.

Trial Profile

Velcade for Proliferative Lupus Nephritis.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 23 Apr 2012

At a glance

  • Drugs Bortezomib (Primary)
  • Indications Lupus nephritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Apr 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by record.
    • 19 Aug 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2012 as reported by
    • 23 Aug 2010 Status changed from not yet recruiting to recruiting as reported by record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top